Disappearance of serum HCV-RNA after short-term prednisolone therapy in a patient with chronic hepatitis C associated with autoimmune hepatitis-like serological manifestations

Journal of Gastroenterology

Volumn 34, Issue 2, 1999, Pages 269-274

  Yoshikawa, Masahide ^a   Toyohara, Masahisa ^a   Yamane, Yoshiko ^a   Mimura, Mayumi ^a   Miyamoto, Yoji ^a   Ueda, Shigehiko ^a   Kawamoto, Hiroshi ^a   Fukui, Hiroshi ^a   Kobayashi, Tatsuro ^b   Hayashi, Eijiro ^b   Nakamura, Akira ^c  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b OSAKA PREFECTURAL MEDICAL CENTER FOR RESPIRATORY AND ALLERGIC DISEASES   (Japan)

^c Sanda Municipal Hospital   (Japan)

Author keywords

Autoimmune hepatitis; Chronic hepatitis C; Corticosteroid; HCV infection

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTINUCLEAR ANTIBODY; CORTICOSTEROID; IMMUNOGLOBULIN G; PREDNISOLONE; VIRUS RNA;

AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; CHRONIC ACTIVE HEPATITIS; CLINICAL FEATURE; CORTICOSTEROID THERAPY; ECHOGRAPHY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LIVER BIOPSY; LIVER FUNCTION TEST; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; BIOPSY; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPATITIS, AUTOIMMUNE; HUMANS; PREDNISOLONE; RNA, VIRAL; SEROLOGIC TESTS; VIREMIA;

EID: 0032939633     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050256     Document Type: Article

References (27)

1. Soloway RD, Summerskill WHJ, Baggenstoss A, Geall MG, Gitni k GL, Elveback IR, Schoenfield LJ. Clinical biochemical and histological remission in severe chronic active liver disease: A controlled study of treatments and early prognosis. Gastroenterology 1972;63:820-33.
2. Cook GC, Mulligan R, Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med 1971;40:159-85.
3. Murray-Lyon IM, Stern RB, Williams R. Controlled trial of prednisolone and azathioprine in active chronic hepatitis. Lancet 1973;I:735-7.
4. Zeniya M, Aizawa Y, Watanabe F, Kawabe T, Hara M, Sakaguchi M, Toda G. HCV-marker-positive autoimmune-type chronic active hepatitis: a possible relation between HCV infection and liver autoreaction. Liver 1994;14:206-12.
5. Bellary S, Schiano T, Hartman G, Black M. Chronic hepatitis with combined features of autoimmune chronic hepatitis and chronic hepatitis C: favorable response to prednisone and azathioprine. Ann Intern Med 1995;123:32-4.
6. Fong TL, Valinluck B, Govindarajan S, Charboneau F, Adkins RH, Redeker AG. Short-term prednisone therapy affects amino-transferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology 1994;107:196-9.
7. Liaw YF, Sheen IS, Lin SM, Chen TJ, Chu CM. Effects of prednisolone pretreatment in interferon alfa therapy for patients with chronic non-A, non-B (C) hepatitis. Liver 1993;13:46-50.
8. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993;18:998-1005.
9. Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 1990;60:215-22.
10. Sanchez-Pescador R, Sheridan PJ, Detmer JJ, et al. Quantitative detection of HCV RNA in human sera using a chemoluminesscent signal amplification oligonucleotide probe assay (abstract). Hepatology 1992;16:588.
11. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949, 140;659-62.
12. Toda G, Zeniya M, Watanabe F, Imawari M, Kiyosawa K, Nishioka M. Present status of autoimmune hepatitis in Japan-correlating the characteristics with international criteria in an area with a high rate of HCV infection. J Hepatol 1997;26:1207-12.
13. Cassini F, Cataleta M, Valentini P, et al. Serum autoantibodies in chronic hepatitis C: Comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 1997;26:561-6.
14. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, Bonkovsky HL. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995;21:613-9.
15. García-Buey L, García-Monzón C, Rodriguez S, Borque MJ, García Sánchez A, Iglesias R, et al. Latent autoimmune hepatitis in patients with chronic hepatitis C. Gastroenterology 1995; 108:1770-7.
16. Papo T, Marcellin P, Bernuau J, Durand F, Poynard T, Benhamou JP. Autoimmune chronic hepatitis exacerbated by alpha interferon. Ann Intern Med 1992;116:51-3.
17. Shindo M, DiBisceglie AM, Hoofnagle JH. Acute exacerbations of liver disease during interferon alfa therapy for chronic hepatitis C. Gastroenterology 1992;102:1406-8.
18. Calleja JL, Albillos A, Cacho G, Iborra J, Abreu L, Escartin P. Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies. J Hepatol 1997;24:308-12.
19. Provenzano G, Almasio P, Fabiano C, Magrin S, Pinzello G, Vaccaro A, Craxì A. Interferon and steroid treatment in patients with chronic hepatitis C and antinuclear or anti-liver-kidney microsomal antibodies. Ital J Gastroenterol 1996;28:377-80.
20. Toda G. Interferon or corticosteroid: treatment of patients with chronic hepatitis C positive for serum markers of autoimmune diseases. Intern Med 1997;36:233-5.
21. Laskus T, Slusarczyk J, Cianciara T, Loch T. Exacerbation of chronic active hepatitis type B after short-term corticosteroid therapy resulting in fatal liver failure. Am J Gastroenterol 1990;85:1414-6.
22. Pinto PC, Hu E, Bernstein-Singer M, Pinter-Brown L, Govindarajan S. Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis B. Cancer 1990;65:878-84.
23. Onwubalili JK. Fulminant hepatic failure in nephrotic syndrome related to withdrawal of immunosuppressive therapy. Postgrad Med J 1988;64:325-7.
24. Magrin S, Craxi A, Fabiano C, Simonetti RG, Fiorentino G, Marino L, et al. Hepatitis C viremia in chronic liver disease: relationship to interferon-α or corticosteroid treatment. Hepatology 1994;19:273-9.
25. Takahashi T, Sano N, Honda H, Ito S. Corticosteroid-induced HCV-RNA positivity in a case of autoimmune hepatitis (in Japanese with English abstract). Acta Hepatol Jpn 1996; 37:276-80.
26. Ando K, Hiroishi K, Kaneko T, Moriyama T, Muto Y, Kayagaki N. et al. Perforin, Fas/Fas ligand, and TNF-α pathways as specific and bystander killing mechanisms of hepatitis c virus-specific human CTL. J Immunol 1997;158:5283-91.
27. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992;149:3339-44.